Literature DB >> 30880636

Muscle Performance and Postural Stability Are Reduced in Patients with Newly Diagnosed Graves' Disease.

Sofie Malmstroem1, Diana Grove-Laugesen1, Anne Lene Riis2, Bjarke Johannessen Bruun3, Eva Ebbehoj1, Klavs Würgler Hansen4, Torquil Watt5,6, Lars Rejnmark1.   

Abstract

Background: Reduced muscle strength is an acknowledged symptom of Graves' disease, but the knowledge on severity is sparse. This study aimed to investigate muscle strength, balance, and muscle function in patients with Graves' disease compared to age- and sex-matched healthy controls.
Methods: Using a cross-sectional design, 55 patients newly diagnosed with Graves' disease were compared to 55 euthyroid controls, matched on sex, age, and menopausal status. Isometric muscle strength (N) and maximum force production (N/s) were measured across different muscles groups using a dynamometer chair and postural stability (balance) in different positions using a stadiometer. Muscle function was assessed using the Timed-Up-and-Go test and the Repeated Chair Stand test.
Results: Patients and controls were well matched. Handgrip maximum muscle strength as well as strength at elbow and knee flexion and extension were significantly impaired in patients compared to controls. Maximum force production was only significantly reduced at elbow flexion. Patients performed the Timed-Up-and-Go and the Repeated Chair Stand test significantly slower than controls, and postural stability was significantly reduced in patients compared to controls in all positions. Free triiodothyronine correlated with reduced muscle strength and postural stability. Conclusions: At the time of diagnosis, Graves' disease is associated with impaired maximum muscle strength, performance, and balance, whereas maximum force production is overall comparable to euthyroid controls.

Entities:  

Keywords:  Graves' disease; autoimmune disease; balance; muscle strength; thyroid

Year:  2019        PMID: 30880636     DOI: 10.1089/thy.2018.0318

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Effect of 9 months of vitamin D supplementation on arterial stiffness and blood pressure in Graves' disease: a randomized clinical trial.

Authors:  Diana Grove-Laugesen; Sofie Malmstroem; Eva Ebbehoj; Anne Lene Riis; Torquil Watt; Klavs Würgler Hansen; Lars Rejnmark
Journal:  Endocrine       Date:  2019-07-06       Impact factor: 3.633

2.  Arterial Stiffness and Blood Pressure in Patients Newly Diagnosed with Graves' Disease Compared with Euthyroid Controls.

Authors:  Diana Grove-Laugesen; Sofie Malmstroem; Eva Ebbehoj; Anne Lene Riis; Torquil Watt; Lars Rejnmark; Klavs Würgler Hansen
Journal:  Eur Thyroid J       Date:  2020-02-14

3.  Lower Leg Arterial Calcifications Assessed by High-Resolution Peripheral Quantitative Computed Tomography in Hypoparathyroid and Pseudohypoparathyroid Patients.

Authors:  Catharina Vind Nielsen; Line Underbjerg; Diana Grove-Laugesen; Tanja Sikjaer; Lars Rejnmark
Journal:  Calcif Tissue Int       Date:  2021-02-12       Impact factor: 4.333

4.  Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease.

Authors:  Daiki Setoyama; Ho Yeop Lee; Ji Sun Moon; Jingwen Tian; Yea Eun Kang; Ju Hee Lee; Minho Shong; Dongchon Kang; Hyon-Seung Yi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-12-30       Impact factor: 12.910

5.  Graves' hyperthyroidism induced pancytopenia, epilepsia and muscle weakness: A case report.

Authors:  Bao Fu; Dinghong He; Zhengguang Geng; Xiaoyun Fu
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

Review 6.  Levothyroxine Therapy in Elderly Patients With Hypothyroidism.

Authors:  Grigoris Effraimidis; Torquil Watt; Ulla Feldt-Rasmussen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.